Table 2.
Demographic Characteristics of UCSF combination HIV cure trial participants (San Francisco, CA).
| Participant Identification Number | Age | Sex Assigned at Birth | Race and Ethnicity | Duration of ATI (days) |
|---|---|---|---|---|
| Post-ATI Interview Accepters | ||||
| 02 | <50 | Male | Declined to Answer, Hispanic | >300 days |
| 03 | >50 | Male | White, Non-Hispanic | 200–300 days |
| 04 | <50 | Male | White, Hispanic | 200–300 days |
| 05 | >50 | Male | White, Non-Hispanic | 100–200 days |
| 06 | >50 | Male | White, Non-Hispanic | >300 days |
| 07 | <50 | Male | White, Non-Hispanic | 200–300 days |
| 10 | <50 | Male | White, Hispanic | >300 days |
| Post-ATI Interview Decliners * | ||||
| 01 | <50 | Male | White, Hispanic | 100–200 days |
| 08 | <50 | Male | Declined to Answer, Hispanic | 100–200 days |
| 09 | <50 | Male | White, Hispanic | 100–200 days |
*
01 and 09 declined post-ATI interview due to time constraints. 08 declined post-ATI interview due to lack of privacy to conduct interview. To maintain confidentiality, only birth sex is indicated, as there was only one transgender individual in the study.